Acute effects of Red Bull energy drink on ventricular repolarization in healthy young volunteers: a prospective study

Ali Elitok, Fahrettin Öz, Cafer Panc, Remzi Sarıkaya, Selim Sezikli, Yasin Pala, Övgü Sinem Bugan, Müge Ateş, Hilal Parıldar, Mustafa Buğra Ayaz, Adem Atıcı, Hüseyin Oflaz, Ali Elitok, Fahrettin Öz, Cafer Panc, Remzi Sarıkaya, Selim Sezikli, Yasin Pala, Övgü Sinem Bugan, Müge Ateş, Hilal Parıldar, Mustafa Buğra Ayaz, Adem Atıcı, Hüseyin Oflaz

Abstract

Objective: Energy drinks (EDs) are widely consumed products of the beverage industry and are often chosen by teenagers and young adults. Several adverse cardiovascular events and malignant cardiac arrhythmias following consumption of EDs have been reported in the literature. Several studies have suggested that the interval from the peak to the end of the electrocardiographic T wave (Tp-e) may correspond to the dispersion of repolarization and that an increased Tp-e interval and Tp-e/QT ratio are associated with malignant ventricular arrhythmias. This study investigated the acute effects of Red Bull ED on ventricular repolarization as assessed by the Tp-e interval and Tp-e/QT ratio.

Methods: A prospective, open-label study design was used. After an 8-h fast, 50 young, healthy subjects consumed 355 mL of Red Bull ED. The Tp-e interval, Tp-e/QTc ratio, and several other electrocardiographic parameters were measured at baseline and 2 h after ingestion of Red Bull ED.

Results: No significant changes in the Tp-e interval or Tp-e/QTc ratio were observed with Red Bull ED consumption. Red Bull ED consumption led to increases in both systolic and diastolic blood pressures, which were associated with an increased heart rate.

Conclusion: Although ingestion of Red Bull ED increases the heart rate and diastolic and systolic blood pressures, it does not cause alterations in ventricular repolarization as assessed by the Tp-e interval and Tp-e/QTc ratio.

Conflict of interest statement

Conflict of interest: None declared.

References

    1. Hoffman JR, Faigenbaum AD, Ratamess NA, Ross R, Kang J, Tenenbaum G. Nutritional supplementation and anabolic steroid use in adolescents. Med Sci Sports Exerc. 2008;40:15–24. [CrossRef]
    1. Higgins JP, Tuttle TD, Higgins CL. Energy beverages: content and safety. Mayo Clin Proc. 2010;85:1033–41. [CrossRef]
    1. Goldfarb M, Tellier C, Thanassoulis G. Review of published cases of adverse cardiovascular events after ingestion of energy drinks. Am J Cardiol. 2014;113:168–72. [CrossRef]
    1. Adverse event reports allegedly related to 5-Hour Energy, Monster and Rockstar. US Food and Drug Administration. [Accessed on March 1 2013]. Available at: .
    1. Gunja N, Brown JA. Energy drinks: health risks and toxicity. Med J Aust. 2012;196:46–9. [CrossRef]
    1. Jones G. Caffeine and other sympathomimetic stimulants: modes of action and effects on sports performance. Essays Biochem. 2008;44:109–23. [CrossRef]
    1. Myers MG. Effects of caffeine on blood pressure. Arch Intern Med. 1998;37:29–33.
    1. Whitsett TL, Manion CV, Christensen HD. Cardiovascular effects of coffee and caffeine. Am J Cardiol. 1984;53:918–22. [CrossRef]
    1. Satoh H. Cardiac actions of taurine as a modulator of the ion channels. Adv Exp Med Biol. 1998;442:121–8. [CrossRef]
    1. McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine. JAMA. 2014;291:216–21. [CrossRef]
    1. Worthley MI, Prabhu A, De Sciscio PSchultz C, Sanders IP, Willoughby SR. Detrimental effects of energy drink consumption on platelet and endothelial function. Am J Med. 2010;123:184–7. [CrossRef]
    1. Higgins JFF, Babu KM. Caffeine reduces myocardial blood flow during exercise. Am J Med. 2013;126:731–8. [CrossRef]
    1. MacCornack FA. The effects of coffee drinking on the cardiovascular system: experimental and epidemiological research. Prev Med. 1977;6:104–19. [CrossRef]
    1. Kors JA, Ritsema van Eck HJ, van Herpen G. The meaning of the Tp-Te interval and its diagnostic value. J Electrocardiol. 2008;41:575–80. [CrossRef]
    1. Morin DIP, Saad MN, Shams OF, Owen JS, Xue JQ, Abi-Samra FM, et al. Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction. Europace. 2012;14:1172–9. [CrossRef]
    1. Seifert SM, Schaechter JL, Hershorin ER, Lipshultz SE. Health effects of energy drinks on children, adolescents, and young adults. Pediatrics. 2011;127:511–28. [CrossRef]
    1. Benowitz NL, Osterloh J, Goldschlager N, Kaysen G, Pond S, Forhan S. Massive catecholamine release from caffeine positioning. JAMA. 1982;248:1097–98. [CrossRef]
    1. Cannon ME, Cooke CT, McCarthy JS. Caffeine-induced cardiac arrhythmia: an unrecognized danger of healthfood products. Med J Aust. 2001;174:520–1.
    1. Myers MG. Caffeine and cardiac arrhythmias. Ann Intern Med. 1991;114:147–50. [CrossRef]
    1. Dobmeyer DJ, Stine RA, Leier CV, Greenberg R, Schaal SF. The arrhythmogenic effects of caffeine in human beings. N Engl J Med. 1983;308:814–6. [CrossRef]
    1. Read WO, Byrne JE. Effect of taurine on the refractory period of heart muscle. Physiologist. 1966;9:273.
    1. Ammar R, Song JC, Kluger J, White CM. Evaluation of electrocardiographic and hemodynamic effects of caffeine with acute dosing in healthy volunteers. Pharmacotherapy. 2001;21:437–42. [CrossRef]
    1. Sutherland DJ, McPherson DD, Renton KW, Spencer CA, Montague TJ. The effect of caffeine on cardiac rate, rhythm, and ventricular repolarization. Analysis of 18 normal subjects and 18 patients with primary ventricular dysrhythmia. Chest. 1985;87:319–24. [CrossRef]
    1. Steinke L, Lanfear DE, Dhanapal V, Kalus JS. Effect of “energy drink” consumption on hemodynamic and electrocardiographic parameters in healthy young adults. Ann Pharmacother. 2009;43:596–602. [CrossRef]
    1. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res. 1991;68:1729–41. [CrossRef]
    1. Shimizu M, Ino H, Okeie K, Yamaguchi M, Nagata M, Hayashi K. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol. 2002;25:335–9. [CrossRef]
    1. Lubinski A, Lewicka-Nowak E, Kempa M, Baczynska AM, Romanowska I, Swiatecka G. New insight into repolarization abnormalities in patients with congenital long QT syndrome: the increased transmural dispersion of repolarization. Pacing Clin Electrophysiol. 1998;21:172–5. [CrossRef]
    1. Castro Hevia J, Antzelevitch C, Tornés Bárzaga IF, Dorantes Sánchez M, Dorticós Balea F, Zayas Molina R. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol. 2006;47:1828–34. [CrossRef]
    1. Savoca MR, MacKey ML, Evans CD, Wilson M, Ludwig DA, Harshfield GA. Association of ambulatory blood pressure and dietary caffeine in adolescents. Am J Hypertens. 2005;18:116–20. [CrossRef]
    1. Savoca MR, Evans CD, Wilson ME, Harshfield GA, Ludwig DA. The association of caffeinated beverages with blood pressure in adolescents. Arch Pediatr Adolesc Med. 2004;158:473–7. [CrossRef]

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe